Tag : Matter Neuroscience

Clinical Research, Pharma & Healthcare Financing

Alto Neuroscience: PAX-D Study Published in The Lancet Psychiatry

Business Wire
by Business Wire078
–  Compelling PAX-D results guided Alto’s acquisition of ALTO-207, designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – –  Alto...
Workforce Development & Leadership

Matter Neuroscience Partners with Stanford for fMRI Neurofeedback in Depression

PR Newswire
by PR Newswire0152
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. Matter Neuroscience...